Axsome Therapeutics (AXSM) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52% |
| Dec 31, 2025 | 0.73% |
| Sep 30, 2025 | -7.35% |
| Jun 30, 2025 | -0.70% |
| Mar 31, 2025 | 4.58% |
| Dec 31, 2024 | 3.65% |
| Sep 30, 2024 | -3.69% |
| Jun 30, 2024 | 4.76% |
| Mar 31, 2024 | 14.18% |
| Dec 31, 2023 | 7.30% |
| Sep 30, 2023 | 4.69% |
| Jun 30, 2023 | -77.33% |
| Mar 31, 2023 | -22.73% |
| Dec 31, 2022 | 11.73% |
| Sep 30, 2022 | -210.00% |
| Jun 30, 2022 | 13.35% |
| Mar 31, 2022 | 2.05% |
| Dec 31, 2021 | 24.54% |
| Sep 30, 2021 | 18.85% |
| Jun 30, 2021 | 14.24% |
| Mar 31, 2021 | 10.45% |
| Dec 31, 2020 | 9.13% |
| Sep 30, 2020 | -6.12% |
| Jun 30, 2020 | 3.36% |
| Mar 31, 2020 | 10.30% |
| Dec 31, 2019 | -404.03% |
| Sep 30, 2019 | 18.81% |
| Jun 30, 2019 | -26.11% |
| Mar 31, 2019 | -205.14% |
| Dec 31, 2018 | 8.23% |
| Sep 30, 2018 | 25.21% |
| Jun 30, 2018 | 23.58% |
| Mar 31, 2018 | 21.72% |
| Dec 31, 2017 | -7.41% |
| Sep 30, 2017 | 16.64% |
| Jun 30, 2017 | 15.60% |
| Mar 31, 2017 | -22.94% |
| Dec 31, 2016 | -8.06% |
| Sep 30, 2016 | 12.55% |
| Jun 30, 2016 | 12.08% |
| Mar 31, 2016 | 8.24% |
| Dec 31, 2015 | -939.55% |
| Sep 30, 2015 | 27.96% |
| Jun 30, 2015 | -279.45% |